Delivery Order SPE2DB22D3004-SPE2DB25FSH35
- Not listed
- The Defense Logistics Agency awarded a $1,086.58 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $5,050.63 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on August 18, 2025, with completion targeted for August 19, 2025. The contract employs firm fixed pricing under a non-competitive delivery order structure and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a ceiling value of $8,630.84. This firm fixed-price delivery order, which is set to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The medication will be fulfilled from...
- The Defense Logistics Agency awarded a $2,007.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The place of performance is listed as AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,285.58 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors (0.5 mL). This firm fixed-price, non-set-aside contract is set to be completed by August 18, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,178.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,295.38 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors. This firm fixed-price contract, with a completion date of September 10, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor will perform this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price, non-competitive delivery order represents a pediatric or standard-dose diabetes medication supply fulfilling federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSH35Delivery Order
The Defense Logistics Agency awarded a $4,204.20 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a completion date of September 5, 2025. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. The product will be performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. As a critical vendor for military and veteran healthcare systems, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies through its DLA contracts, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The broader SPE2DX IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply military healthcare programs worldwide, with products distributed to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order represents one of numerous competitively awarded transactions under the indefinite contract vehicle, reflecting AmerisourceBergen's established capability to fulfill federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/4/25 |